Nonalcoholic Fatty Liver Disease: A New Frontier for Hepatology in Bangladesh and a Call for Action to Combat

Authors

  • Shahinul Alam Associate Professor, Dept. of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • M Motahar Hossain Culsultant, Gastroenterology and Hepatology, Square Hospital, Dhaka
  • Golam Azam Assistant Professor of Gastroentestinal Liver and Pancreatic Disease, BIRDEM, Dhaka
  • Golam Mustafa Associate Professor, Dept. of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Mahbubul Alam Medical Officer, Dept. of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • Abu Sayeed Professor of Medicine (Rtd.), Chittagong Medical College, Chittagong
  • Mobin Khan Professor and Chairman (Rtd), Dept. of Hepatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka
  • Nooruddin Ahmad Professor and Chieman, Dept. of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka

DOI:

https://doi.org/10.3329/jbcps.v35i4.34739

Keywords:

Fatty liver, Bangladesh, Prevalence, Cirrhosis, Non-communicable disease

Abstract

Nonalcoholic Fatty Liver Disease (NAFLD) is the condition where fat accumulates in liver without significant ingestion of alcohol. NAFLD has become one of the most common liver conditions throughout the world. At the dawn of the history of NAFLD it was thought that NAFLD is disease of obese individual but lean patients are increasingly detected to have NAFLD. It seems that insulin resistance is central to the pathogenesis of NAFLD. In addition, oxidative stress and cytokines are important contributing factors, resulting in steatosis and progressive liver damage in genetically susceptible individuals. NAFLD varies considerably by ethnic group and Bangladeshi ethnicity is an independent risk factor for NAFLD. Prevalence of NAFLD in general population of Bangladesh is 4 - 18.4 %, which jumps up to 49.8% in diabetic patients. With the changes in socioeconomic condition and life style, aetiology of chronic liver disease is drifting from infectious to noninfectious diseases and the contribution of NAFLD is progressively increasing. Hepatitis B and hepatitis C have been the leading causes of mortality and morbidity from chronic liver disease in Bangladesh. But with increase in awareness and mass vaccination against HBV, prevalence of both the diseases has been decreasing in the country. The most alarming feature is that there is a high prevalence of NASH among the NAFLD patients. NAFLD is emerging as the largest contributor of chronic liver disease in Bangladesh. This warrants the attention of health policy makers and clinicians to explore this frontier and combat it from right now.

J Bangladesh Coll Phys Surg 2017; 35(4): 184-191

Downloads

Download data is not yet available.
Abstract
2485
PDF
1489

Downloads

Published

2017-11-30

How to Cite

Alam, S., Hossain, M. M., Azam, G., Mustafa, G., Alam, M., Sayeed, A., Khan, M., & Ahmad, N. (2017). Nonalcoholic Fatty Liver Disease: A New Frontier for Hepatology in Bangladesh and a Call for Action to Combat. Journal of Bangladesh College of Physicians and Surgeons, 35(4), 184–191. https://doi.org/10.3329/jbcps.v35i4.34739

Issue

Section

Review Articles